lilly glp 1 oral approval is now pharma's top revenue company. It just got FDA for an GLP-1, but Wall Street isn't celebrating GLP-1 receptor agonists Lilly's oral GLP-1 succeeds in

Based on the results of previous studies, it seems that L-carnitine needs a longer duration of use to have significant effects on glycemic indices-related markers in diabetic patients (87)

Thanks for mentioning us in the "sweet spot" of your middle pillar

[Abstract]2021 May 28;41(6):BSR20204250

(2022) 3:R96R108

Dietary intakes of choline and betaine and risk of cardiovascular disease Because both folate- and choline-dependent metabolic pathways catalyze the re-methylation of homocysteine, dietary intakes of both nutrients need to be considered when the association between homocysteine concentrations and cardiovascular disease is assessed